Potential Antidiabetic Activities of Probiotic Strains, L. acidophilus and L. bulgaricus against Fructose-Fed Hyperglycemic Rats

Background: Deregulation of the gut microbiota results in various pathological disorders such as diabetes, inflammation, cancer, 
dyslipidemia etc. Modulation of intestinal microbiota by probiotics may 
facilitate the management of a number of clinical conditions of diabetes. Methods: The present study was designed to investigate the effect of feeding low-fat 
probiotic yogurt containing L. acidophilus and L. bulgaricus on 
fructose-fed hyperglycemic rats. Yogurt 
containing L. acidophilus or L. bulgaricus (9.5 × 109 cfu/rat/day) alone or in combination of both strains was supplied 
orally for 8 weeks concurrently with 20% fructose solution. Fasting blood 
glucose (FBG), oral glucose tolerance test, glycosylated hemoglobin (HbA1c), 
lipid profiles from blood and histopathological study of liver tissues were 
analyzed to evaluate anti-diabetic effect. 
Statistical analysis was done by Graph Pad Prism software. Values at p 0.05 were considered statistically significant. Results: Administration 
of L. acidophilus or L. bulgaricus alone or in combination of 
both to hyperglycemic rats decreased serum FBG, onset of glucose intolerance, HbA1c, total 
cholesterol, triglycerides, LDL and VLDL-cholesterol, increased HDL-cholesterol levels significantly and preserved 
antioxidant pool such as activities of superoxide dismutase, catalase etc. 
Probiotic administration also prevented/repaired the oxidative damage of liver tissues. Conclusion: In conclusion, 
administration of yogurt containing L. acidophilus or L. bulgaricus that balanced the intestinal 
microbiota can prevent or lower risks of type-2 diabetes 
and its related complications.


Introduction
Diabetes is a condition of multifactorial origin, involving several molecular mechanisms related to the intestinal microbiota for its development [1]. Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population [2].
According to International Diabetes Federation Diabetes Atlas 2017, diabetes affects more than 425 million people worldwide and the number of people with diabetes may rise to 629 million in 2045. At the same time, a further 352 million people with impaired glucose tolerance are at high risk of developing diabetes [3]. It has been estimated that globally as many as 212.4 million people or half (50.0%) of all people 20 -79 years with diabetes are unaware of their disease.
According to WHO-diabetes country profiles 2016 [4], in Bangladesh, the prevalence of diabetes is 8.0%, which is alarming for the population as well as for government. Scientific evidences suggest that increased inflammatory stress is related to molecular mechanisms leading to insulin resistance, and the intestinal microbiota interacts with environmental factors and susceptible genetic factors, contributing to the development of diabetes [5] [6] [7]. Deregulation of these microbiota component results in various pathological disorders such as cancer, diabetes, cardiovascular diseases, dyslipidaemia etc. [8] [9]. Modulation of intestinal microbiota by probiotics may facilitate the management of a number of clinical conditions [10]. Probiotics may be involved in the maintenance of a healthier gut microbiota that would be beneficial for the management of diabetes. The present study aimed to investigate the effect of probiotic, lactobacillus (L) strains, L. acidophilus and L. bulgaricus in the form of functional food, yogurt, against fructose-fed hyperglycemic rats.

Reagents and Materials
"Probio" capsule manufactured by Square Pharmaceuticals Ltd., Bangladesh. MRS agar media (Hi Media Laboratories, India), Low fat milk (Pran company ltd., Bangladesh), total cholesterol triglyceride and high density lipoprotein assay kits (Cell Biolabs, Inc., San Diego), blood sugar assay kits (One touch ultra, California, United States) and other reagent grade necessary chemicals were purchased from elsewhere.

Collection of Commercial Probiotic Sample and Culture in MRS Media
Commercial probiotic sample "Probio" (0.5 gm/capsule) manufactured by

Experimental Animal
Thirty, white male Wistar rats, 6 weeks of age were purchased from animal centre, department of pharmacy, Jahangirnagar University, Dhaka, Bangladesh. The rats were kept in polypropylene rat cages throughout the study. They were housed in a temperature-controlled (24˚C ± 1˚C) room and standardized light/dark

Doses and Treatment
Hyperglycemia model was developed in animals by giving 20% fructose solution in drinking water ad libitum for a period of 8 weeks [12] [13] [14] with concurrent administration of yogurt containing lactobacillus strains (ca 9.5 × 10 9 cfu/rat/day).

Experimental Design
Healthy rats with a mean body weight of 100 -130 g were subdivided into six groups of five animals in each group.

Monitoring Blood Glucose Level during Experimental Period
The blood glucose level of the rats was observed weekly. Blood samples were collected from the tail vein and glucose concentration was determined with a glucometer (One touch ultra, California, United States).

Oral Glucose Tolerance Test (OGTT)
OGTT was performed after the eight weeks of the experimental period according to the protocol described in a previous report [17]. After an overnight fast (12 h), rats were orally dosed with a D-glucose solution (2.0 g/kg of body weight) by orogastric gavage and blood glucose levels were measured at 0, 30, 60, 90, and 120 minutes after the oral dosing of glucose by glucometer.

Blood and Liver Tissue Sampling
At the end of the experimental period, rats were euthanized by chloroform anesthesia and then cervical decapitation and dissection. Blood samples were collected and liver was excised for biochemical as well as for histopathological studies. Blood sample was collected from jugular vein of each animal (5 ml) in a centrifuge tube and left to clot at room temperature for 45 min. Sera were separated by centrifugation at 4000 r.p.m. at 4˚C for 10 min and kept frozen at −20˚C for various physiological and biochemical analyses. Liver from each animal was excised after dissection. One part was fixed in buffered formalin for 24 h, trimmed and then transferred into 70% alcohol for histopathological examination. 0.5 g was homogenized in 5 ml phosphate buffered solution (PBS) using polytron homogenizer (IKA, Japan).

Biochemical Analyses
Serum total cholesterol, triglyceride, and high-density lipoprotein (HDL) levels were determined colorimetrically by using assay kits according to the manufacturer protocol (Cell Biolabs, Inc., San Diego). Low-density lipoprotein (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) levels were calculated by using Friedewald's equation [18]. Liver catalase activity was assayed following the method of Kar and Mishra, 1976 [19]. Liver superoxide dismutase (SOD) activity is assayed according to the method of Marklund and Marklund [20].

Histopathological Studies of Liver Tissues
Liver tissues preserved in 10% neutral buffered formalin were treated according to a standard laboratory protocol. Embedded sections were cut at a size of 5 μm.

Statistical Analysis
Statistical analysis was carried out by using a statistical software package Graph Pad Prism 7.0 (San Diego, CA, USA). All data are presented as the mean ± SEM (standard error of the mean). Differences among groups were assessed by one-way analysis of variance (ANOVA). Student t-test was used for comparison between two groups. Values at p < 0.05 were considered statistically significant.

Characterization of Probiotic Strains for the Preparation of Yogurt and Subsequent Colony Count
Morphological, physiological and biochemical examination of probiotics ( Table   1), suggested that the isolated strains from the commercial product "Probio" were Lactobacillus (L) acidophilus (LAB-A) and L. bulgaricus (LAB-B) that all features consistent to previous reports [21] [22]. After preparation of yogurt by inoculating probiotic strain L. acidophilus or L. bulgaricus in low fat UHT liquid milk at 37˚C for 48 hours, colonies were counted. The yogurt inoculated by L. acidophilus was contained 9.73 billion (9.73 × 10 9 ) viable L. acidophilus cells per gram and the yogurt inoculated by L. bulgaricus contained 9.57 billion (9.57 × 10 9 ) viable L. bulgaricus cells per gram.

Evaluation of Antidiabetic Activity of Probiotics
The parameters of fasting blood glucose (FBG) level, oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) were estimated to investigate the effect of probiotics in fructose-fed hyperglycemic rats. As shown in Figure   1(A), oral administration of 20% (w/v) fructose for a period of 8 weeks caused progressive and stable hyperglycemia. Simultaneous administration of yogurt containing the probiotic L. acidophilus, AF or L. bulgaricus, BF or in a combination of both L. acidophilus and L. bulgaricus, ABF (ca 9.5 × 10 9 colonies/rat/day) significantly decreased the fructose-fed excessive load of blood glucose level. In the present study, oral glucose tolerance test (OGTT) has been done to investigate the glucose intolerance in the experimental rats. As shown in Figure 1 (Figure 1(C)). The effect of ABF (combination of both L. acidophilus and L. bulgaricus) was more prominent than the strain individually. These results strongly suggest that those probiotics have potential antidiabetic effects. During experimental period, we investigated rat's weight. Our findings showed a slight increase in rat's weight after treatment in all groups. However, these variations did not reveal a significant difference in the mean body weight between the studied groups of rats at the end of the experimental period.

Effect of Probiotics on Serum Lipid Profiles in Fructose-Fed Hyperglycemic Rats
Lipid profiles are highly variable in type 2 diabetes. After the experimental period, rats blood serum were collected and investigated the serum total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), VLDL and HDL levels according to the manufacturer's protocol as described in the Methods section. As shown in Table 2, administration of lactobacillus strains, AF, BF or ABF significantly reduced the fructose-induced elevation of TC, TG, LDL, and VLDL levels and increased HDL levels.
control group. In normal control group, the lobular structure remained unaltered, central vein were intact, sinusoids and Kupffer cells were normal as shown in Figure 2(A). However, in DC-diabetic group's rats liver tissues, there was congestion of central vein and swelling of hepatocytes (Figure 2(B)). We found that administration of lactobacillus strains; AF, BF or ABF significantly re-established the central vein and normalized hepatocytes as shown in Figures 2(C)-(E), respectively.

Effect of Probiotics on Liver Catalase and Superoxide Dismutase Activity
The activity of endogenous antioxidative liver enzymes, catalase (CAT) and superoxide dismutase (SOD) was measured from the homogenized liver tissues as described in "Methods". Fructose-fed hyperglycemia caused the decrease of liver CAT and SOD activity as compared to the normal control (NC) group suggested that hyperglycemia resulted the excess load of oxidative stress. Administration of probiotic yogurt, containing L. acidophilus or L. bulgaricus alone or both strains, AF, BF or ABF significantly showed high CAT and SOD activity as compared to diabetic control group (Table 3).

Discussion
A well balanced diversity of gut microbiota is an important aspect of health. In the healthy state, potentially pathogenic bacteria are kept under control by the non-pathogenic flora, so called colonization resistance. On the other hand, altered intestinal microbiota referred to as dysbiosis leads to increased intestinal permeability and mucosal immune response, contributing to the development of diabetes [23].
The present study were concentrated to investigate the effect of regular  to be at least 10 6 -10 7 CFU/g to be accepted as the therapeutic minimum [24].
This adequate amount varies from country to country; in Japan a product should contain a minimum of 10 7 colony-forming unit (CFU)/g of probiotic bacteria to be considered a probiotic one, while the USA has developed a standard which requires at least 10 8 CFU/g of the product to be labeled as probiotic [25]. The adequate amount should not be less than 10 8 -10 9 CFU/g of the probiotic [26] [27]. After counting of viable bacterial cell, we confirmed that the CFU of probiotic into prepared yogurt for treatment of diabetics was more than the minimum value. Besides, we cultured rat stoolson MRS media and found the presence of probiotic bacterial species in the specimens. The presence of lactobacilli was much higher in the yogurt treatment group (data not shown) of rat's stools as compared to the normal control group, suggesting the viability of LAB strains in the gut of rats.
Recent studies have concentrated on various strategies to prevent and/or delay the onset of type 2 diabetes and its complications [28]. One of these strategies is the consumption of foods low in the glycemic index with bioactive agents that have been adopted to prevent or delay the onset of disease. Our results indicated that balancing microbiota by L. acidophilus and/or L. bulgaricus significantly prevented or lowered risks of diabetes. High fructose diets have been used in animal models to induce metabolic changes similar to type 2 diabetes. Impaired glucose tolerance testing is an important predictor of type 2 diabetes [29]. Rats treated with Lactobacillus probiotics protected against the development of fructose-induced carbohydrate intolerance. High amount of blood glucose in diabetes mellitus reacts with other biomolecules to form advanced glycated endproducts (AGEs), chiefly HbA1c. The formation/activation of AGEs, transcription factors, and protein kinase C results in an increase in oxidative stress [30] [31]. The increase in the level of HbA1c in the fructose-fed diabetic rats observed in the present study might be due to increase in blood glucose level that was significantly suppressed by Lactobacillus probiotics.
In the present study, we observed that the concentrations of lipids, such as TC, TG, LDL and VLDL were significantly high, and HDL was low in diabetic rats compared to control group. The variation of lipid levels in type 2 diabetics is Liver is the primary organ susceptible to the effects of hyperglycemia-induced oxidative stress, which may lead to liver tissue injury [36] [37], and thus further aggravating diabetes by decreasing insulin sensitivity and/or increasing insulin resistances [38]. Histopathological analyzes have shown that probiotic supplementation protected high fructose-induced liver changes, suggesting that probiotic supplementation kept the normal functions of liver for carbohydrate metabolism. Living organisms possess endogenous enzymatic antioxidative defenses such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR) etc., that repair systems to protect them against oxidative stress [39]. These endogenous antioxidants play the first line of defense against oxidative stresses. Administration of L. acidophilus or L. bulgaricus alone or in combination of both attenuated the hyperglycemia-induced reduction of SOD and CAT. The probiotic-mediated high liver CAT and SOD activity might be the proposed mechanism of how probiotic strains are involved in the prevention and/or repair of oxidative damage of the liver tissues and keeping insulin sensitivity towards the fructose-fed rats.

Conclusion
In conclusion, administration of low fat yogurt containing L. acidophilus or L. bulgaricus to high fructose-fed hyperglycemic rats decreased fructose-induced elevated serum FBG, HbA1c, total cholesterol, triglycerides, LDL and VLDL-cholesterol, and increased HDL-cholesterol levels significantly and preserved antioxidant pool such as activities of superoxide dismutase, catalase etc., which prevented/repaired the oxidative damage of liver tissues. So, our findings indicate that balanced microbiota by L. acidophilus and L. bulgaricus can prevent or lower risks of type-2 diabetes and its related complications. However, further studies necessitate developing functional foods and their clinical trials in human.